Skip to main content
Trusted by 3,500+ International Patients Across 50+ Countries | Speak with a Dedicated Medical Coordinator 24/7 | Personalized Care Every Step of the Way
+91 83682 47758
info@medivisorhealth.com
Medivisor India Treatment Logo
  • Home
    • About Us
    • Our Services
    • Our Team
    • Our Safety Measures
    • Loading treatments...
    • Loading hospitals...
    • Loading doctors...
    • Treatment Cost
    • Treatment Process
    • Visa Process
    • Travel Guide
    • FAQs
    • Why Medivisor
    • Success Stories
    • Patient Activities
    • Social Activities
    • News Coverage
    • Blog
  • Become a Partner

Medivisor India Treatment is a trusted New Delhi–based medical travel partner connecting global patients to advanced, affordable, high-quality healthcare in India.

  • Medivisor House 359, Sector 1, Vaishali, Ghaziabad, (Delhi/NCR) India
  • +91 8368 247 758
  • info@medivisorhealth.com

About Us

  • About Us
  • Our Services
  • Our Team
  • Our Medical Advisors
  • Our Safety Measures
  • Join Our Network
  • Contact Us

India Treatment

  • Hospitals
  • Treatments
  • Treatment Cost
  • Treatment Process
  • Visa Process
  • Travel Guide
  • FAQs
  • Why Medivisor

Gallery

  • Patient Testimonials
  • Patient Activities
  • News Coverage
  • Blog

Get in Touch

© 2026 Medivisor India Treatment. All rights reserved.

Dr Rajasekara Chakravarthi Madarasu

Senior Consultant - Nephrology, Clinical Director & HOD - Nephrology & Transplant Services

30+ years experience

 Dr Rajasekara Chakravarthi Madarasu
  1. Home
  2. Doctors
  3. Dr Rajasekara Chakravarthi Madarasu

About Dr Rajasekara Chakravarthi Madarasu

Dr. Rajasekara Chakravarthi Madarasu is a highly distinguished specialist in nephrology and renal transplantation, recognized for his technical mastery in complex renal replacement therapies, advanced immunosuppressive protocols, and critical care nephrology. He specializes in utilizing precision-guided diagnostic, dialytic, and apheresis platforms to manage severe renal pathologies, optimize allograft survival, and deliver comprehensive, state-of-the-art clinical care for both pediatric and adult patient populations.

Mastery in Advanced Nephrology and Multi-Generational Renal Care

He specializes in the advanced evaluation, diagnostic mapping, and therapeutic management of a wide range of acute and chronic kidney diseases across all age groups. His clinical practice leverages nearly three decades of refined nephrological acumen to design highly tailored treatment interventions for intricate renal disorders, ensuring optimal fluid and electrolyte homeostasis, metabolic stabilization, and long-term preservation of native kidney function.

Innovation in Renal Transplantation and End-Stage Kidney Disease Pathways

Dr. Madarasu possesses profound expertise in implementing state-of-the-art protocols within the domain of renal transplant services. By managing complex pre-transplant workups, highly precise immunological risk stratification, and modern post-transplant immunosuppressive regimens, he navigates high-risk allograft pathways to achieve predictable outcomes, minimize rejection episodes, and enhance long-term patient and graft survival.

Critical Care Nephrology and Advanced Dialytic Therapies

A primary focus of his specialized practice involves the delivery of intensive, detail-driven medical care for critically ill patients experiencing acute kidney injury (AKI) or multi-organ dysfunction. His structured clinical framework encompasses the precise administration of advanced blood purification techniques, automated peritoneal dialysis, high-flux hemodialysis, and continuous renal replacement therapies (CRRT) to maximize physiological stability in acute settings.

Clinical Governance and Senior Institutional Leadership

Throughout his extensive career spanning over 29 years, Dr. Madarasu has combined modern nephrological innovations with rigorous clinical protocols to maintain the highest standards of safety and patient care. Serving as a Senior Consultant Nephrologist, Clinical Director, and Head of Department (HOD) for Nephrology and Transplant Services within the premier institutional framework at Yashoda Hospitals, Hitec City, he remains a trusted authority dedicated to driving elite medical excellence and evidence-based clinical governance.

Dr. Rajasekara Chakravarthi Madarasu at a Glance

  • Specialist in Nephrology, Advanced Dialytic Therapies, and Complex Renal Transplantation.

  • Clinical Director & HOD delivering elite institutional leadership and medical governance at Yashoda Hospitals, Hitec City.

  • Extensive clinical experience with over 29 years of dedicated service in adult and pediatric kidney care.

  • Expert in advanced immunological matching and post-transplant care to optimize graft survival.

  • Highly proficient in directing continuous renal replacement therapies (CRRT) for critical care pathologies.

  • Focused on integrating evidence-based treatment pathways to optimize patient recovery and safety outcomes.

1999: DNB Nephrology, Apollo Hospitals, Chennai
1997: MD Internal Medicine, JSSMC, University of Mysore
1992-1993: Internship, JSSMC Hospital, University of Mysore
1992: MBBS, JSSMC, University of Mysore
Oreopoulos Award for the Best Paper, II PDSI-August 1998, Hyderabad
Travel Grant to attend the 47th Annual Conference of JSDT, July 2002
Travel Grant to attend the 5th Prevention of Renal Disease Conference in Toronto, September 2006
Tanker Award for the Best Paper presented at the ISN Annual Conference, December 2007 in Delhi

Affiliated Hospitals

Yashoda Hospital, Hitec City
Yashoda Hospital, Hitec City

Multi Specialty

Hyderabad, Telangana

2022

Estd.

2000+

Beds

800+

Doctors

May we help you?

Enter digits only (6-15 digits). We'll add your country code.

Related Treatments

Partial Nephrectomy (Kidney-Saving Surgery)
Partial Nephrectomy (Kidney-Saving Surgery)

Partial Nephrectomy Partial Nephrectomy, also known as "Kidney-Sparing Surgery," is a complex procedure where only the diseased part of the kidney (usually a tumor) is removed, leaving the healthy, functioning kidney tissue intact. This is the preferred treatment for smaller kidney tumors to preserve as much renal function as possible. When You Should Consider Partial Nephrectomy Small Renal Masses: Typically the first choice for tumors less than 4 cm (Stage T1a) and many tumors up to 7 cm (Stage T1b). Solitary Kidney: When a patient only has one functioning kidney, making it critical to avoid a total removal. Bilateral Kidney Tumors: When tumors are present in both kidneys, requiring a sparing approach on one or both sides. Pre-existing Kidney Disease: For patients with diabetes or hypertension who are at higher risk for future chronic kidney disease. Genetic Predisposition: For patients with conditions like Von Hippel-Lindau (VHL) syndrome who may develop multiple tumors over their lifetime. Methods of Partial Nephrectomy Robotic-Assisted (Da Vinci): The modern standard for precision. It allows the surgeon to perform complex suturing within the tight "ischemia" time window using 3D magnification. Laparoscopic Surgery: A minimally invasive approach using small incisions and specialized instruments to remove the tumor and repair the kidney. Open Surgery: Often reserved for very large or centrally located tumors where the surgeon needs direct physical access to the kidney. Nerve and Vessel Sparing: A technique focusing on identifying the specific arterial branches feeding the tumor to avoid clamping the entire renal blood supply. Renorrhaphy (Repair): The reconstructive phase where the "hole" left in the kidney is stitched closed using specialized sutures and hemostatic agents. How the Procedure Is Performed Anesthesia: Performed under General Anesthesia to ensure total patient comfort and muscle relaxation. The "Clamping" Phase: To prevent heavy bleeding, the surgeon temporarily clamps the Renal Artery. This must usually be completed in under 20–30 minutes to protect kidney health. Tumor Excision: The surgeon cuts out the tumor along with a small "margin" of healthy tissue to ensure no cancer cells remain. Hemostasis: Specialized "bolsters" or glues are often applied to the raw surface of the kidney to stop bleeding instantly. Unclamping: The artery clamp is removed, and the surgeon verifies that the kidney regains its pink color and shows no signs of active bleeding. Drain Placement: A small tube is left in the side for 24–48 hours to monitor for any internal fluid or blood collection. Pre-Procedure Preparation 3D Imaging: A high-resolution CT Scan or MRI with contrast is mandatory to map the "Renal Nephrometry Score" and tumor depth. Kidney Function Test: A DTPA Scan or serum creatinine test is performed to establish a baseline for how well both kidneys are working. Blood Prep: "Cross-matching" for blood units is done in advance due to the highly vascular nature of the kidney. Medication Audit: You must stop all blood thinners (Aspirin, Warfarin, etc.) 7–10 days prior to the operation. Fasting: Maintaining a "nil per oral" status for 8 hours before the procedure for anesthesia safety. Pre-Surgery Tests Complete Blood Count (CBC): To check baseline hemoglobin levels and ensure the body is ready for surgery. Coagulation Profile: Testing PT/INR and Platelet counts to ensure the kidney repair will clot effectively. Chest X-ray and EKG: Standard pre-operative checks to ensure heart and lung fitness for general anesthesia. Urinalysis: To rule out any existing urinary tract infections before the procedure. Electrolyte Panel: Checking sodium, potassium, and calcium levels to ensure the body’s chemistry is balanced. Life After Partial Nephrectomy (Recovery & Risks) Hospital Stay: Usually 2–3 days for Robotic/Laparoscopic surgery and 4–5 days for the Open approach. Catheterization: A Foley catheter is placed in the bladder for 1–2 days to monitor urine output and filtration. Activity Restrictions: No heavy lifting (over 5kg) or strenuous exercise for 6 weeks to prevent the repair from bleeding. Hydration Therapy: Drinking 2–2.5 litres of water daily is recommended to keep the kidneys working at a steady, healthy pace. Urine Leak Risk: If the repair isn't water-tight, a temporary JJ Stent may be placed to allow the kidney to heal. Follow-Up Imaging: A CT scan is typically repeated at 3 or 6 months to monitor the surgical site and ensure no recurrence. Why Specialized Treatment Is Highly Effective Preservation of Function: By saving the healthy part of the kidney, patients have a much lower risk of requiring dialysis in the future. Oncological Equivalent: Modern studies show that for appropriately selected tumors, a partial removal is just as effective as a total removal for cancer control. Robotic Precision: 2026 robotic technology allows for "ultra-selective clamping," where only the tumor's blood supply is stopped, leaving the rest of the kidney "warm." Faster Recovery: Minimally invasive techniques lead to less pain, smaller scars, and a quicker return to normal life compared to traditional surgery. Lower Cardiovascular Risk: Maintaining two functioning kidneys is linked to better long-term heart health and blood pressure control.

May we help you?

Enter digits only (6-15 digits). We'll add your country code.